Gene · 10987
Papers2,142
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,142
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1-positive regulator for tumor immune evasion. | J Clin Invest | 2023 | 38038129 | PubTator, text mining | PubMed |
| CDK5 destabilizes PD-L1 via chaperon-mediated autophagy to control cancer immune surveillance in hepatocellular carcinoma. | J Immunother Cancer | 2023 | 38007240 | PubTator, text mining | PubMed |
| Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy. | Acta Pharm Sin B | 2023 | 37969742 | PubTator, text mining | PubMed |
| Proteomic-Based Discovery of Predictive Biomarkers for Drug Therapy Response and Personalized Medicine in Chronic Immune Thrombocytopenia. | Biomed Res Int | 2023 | 37942029 | PubTator, text mining | PubMed |
| Systematic analysis of various RNA transcripts and construction of biological regulatory networks at the post-transcriptional level for chronic obstructive pulmonary disease. | J Transl Med | 2023 | 37936118 | PubTator, text mining | PubMed |
| Roles of USP9X in cellular functions and tumorigenesis (Review). | Oncol Lett | 2023 | 37920433 | PubTator, text mining | PubMed |
| DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases. | Biomolecules | 2023 | 37892185 | PubTator, text mining | PubMed |
| Deubiquitylating Enzymes in Cancer and Immunity. | Adv Sci (Weinh) | 2023 | 37888853 | PubTator, text mining | PubMed |
| Involvement of the Macrophage Migration Inhibitory Factor (MIF) in Lipedema. | Metabolites | 2023 | 37887430 | PubTator, text mining | PubMed |
| Identification of BRCC3 and BRCA1 as Regulators of TAZ Stability and Activity. | Cells | 2023 | 37887275 | PubTator, text mining | PubMed |
| DDA1, a novel factor in transcription-coupled repair, modulates CRL4CSA dynamics at DNA damage-stalled RNA polymerase II. | Res Sq | 2023 | 37886519 | PubTator, text mining | PubMed |
| USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7. | PLoS One | 2023 | 37874827 | PubTator, text mining | PubMed |
| DUSP1 Signaling Pathway Regulates Cytarabine Sensitivity in Acute Myeloid Leukemia. | Technol Cancer Res Treat | 2023 | 37872685 | PubTator, text mining | PubMed |
| Targeting USP8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT. | Adv Sci (Weinh) | 2023 | 37867237 | PubTator, text mining | PubMed |
| Hepatocellular Carcinoma Subtyping and Prognostic Model Construction Based on Chemokine-Related Genes. | Med Princ Pract | 2023 | 37848003 | PubTator, text mining | PubMed |
| PD-1/PD-L1 Inhibitors Response in Triple-Negative Breast Cancer: Can Long Noncoding RNAs Be Associated? | Cancers (Basel) | 2023 | 37835376 | PubTator, text mining | PubMed |
| Role of Ubiquitination and Epigenetics in the Regulation of AhR Signaling in Carcinogenesis and Metastasis: "Albatross around the Neck" or "Blessing in Disguise". | Cells | 2023 | 37830596 | PubTator, text mining | PubMed |
| Deubiquitinase OTUD3: a double-edged sword in immunity and disease. | Front Cell Dev Biol | 2023 | 37829187 | PubTator, text mining | PubMed |
| Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume II. | Front Immunol | 2023 | 37822939 | PubTator, text mining | PubMed |
| Green synthesis of nano-based drug delivery systems developed for hepatocellular carcinoma treatment: a review. | Mol Biol Rep | 2023 | 37817020 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10987/papers?page=7